NCT04208347 2026-01-23Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric CancerRuijin HospitalPhase 2/3 Active not recruiting580 enrolled
NCT07309419 2025-12-30Cocktail-001Shanghai Zhongshan HospitalPhase 2/3 Not yet recruiting222 enrolled
NCT04521153 2025-05-11Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular CarcinomaShanghai Zhongshan HospitalPhase 2/3 Active not recruiting294 enrolled